Literature DB >> 19628430

Translating biological insights into clinical endpoints in neuro-oncology.

Markus Bredel1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19628430     DOI： 10.1016/S1470-2045(09)70192-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy.

Authors:  Michelina Festa; Luis Del Valle; Kamel Khalili; Renato Franco; Giosuè Scognamiglio; Vincenzo Graziano; Vincenzo De Laurenzi; Maria Caterina Turco; Alessandra Rosati
Journal:  Am J Pathol       Date:  2011-05-10       Impact factor: 4.307

2.  Growth inhibitory effects of the Diruthenium-Ibuprofen compound, [Ru2Cl(Ibp) 4], in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo.

Authors:  Marcel Benadiba; Iguatinã de M Costa; Rodrigo L S R Santos; Fernanda Oliveira Serachi; Denise de Oliveira Silva; Alison Colquhoun
Journal:  J Biol Inorg Chem       Date:  2014-05-14       Impact factor: 3.358

3.  Bevacizumab improves quality of life in patients with recurrent glioblastoma.

Authors:  Seema Nagpal; Griffith Harsh; Lawrence Recht
Journal:  Chemother Res Pract       Date:  2011-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.